Certain neurons choose the neurotransmitter they use in an activity-dependent manner, and trophic factors are involved in this phenotypic differentiation during development. Developing hippocampal granule cells (GCs) constitutively express the markers of the glutamatergic and GABAergic phenotypes, but when development is completed, the GABAergic phenotype shuts off. With electrophysiological, single-cell reverse transcription-PCR and immunohistological techniques, we show here that short-term (24 h) cultures of fully differentiated adult glutamatergic GCs, which express glutamate, VGlut-1 (vesicular glutamate transporter) mRNA, calbindin, and dynorphin mRNA, can be induced to reexpress the GABAergic markers GABA, GAD 67 (glutamate decarboxylase 67 kDa isoform), and VGAT (vesicular GABA transporter) mRNA, by sustained synaptic or direct activation of glutamate receptors and by activation of TrkB (tyrosine receptor kinase B) receptors, with brain-derived neurotrophic factor (BDNF) (30 min). The expression of the GABAergic markers was prevented by the blockade of glutamate receptors and sodium or calcium channels, and by inhibitors of protein kinases and protein synthesis. In hippocampal slices of epileptic rats and in BDNF-treated slices from naive rats, we confirmed the appearance of monosynaptic GABA A receptor-mediated responses to GC stimulation, in the presence of glutamate receptors blockers. Accordingly, GC cultures prepared from these slices showed the coexpression of the glutamatergic and GABAergic markers. Our results demonstrate that the neurotransmitter choice of the GCs, which are unique in terms of their continuing birth and death throughout life, depends on programmed and environmental factors, and this process is neither limited by a critical developmental period nor restricted by their insertion in their natural network.
Introduction
The choice of a neurotransmitter by differentiating neurons has been related to neuronal identity and to extrinsic influences, whereby the regulation of this process has been shown to be homeostatic. In Xenopus laevis spinal cord, suppression of activity leads to an increased number of neurons expressing excitatory transmitters and a decreased number of neurons expressing inhibitory transmitters; the reverse occurs when activity is enhanced (Borodinsky et al., 2004) . In the rodent developing dentate gyrus (DG), when the activation of GABA receptors and glutamate receptors (GluRs) needs to happen in synergy to activate NMDA receptors (Leinekugel et al., 1997) , the granule cells (GCs) express a dual glutamatergic/GABAergic phenotype (Walker et al., 2001; Gutiérrez et al., 2003; Kasyanov et al., 2004) . After this period, the GABAergic phenotype of the GCs shuts off , but the adult GCs still contain traces of GABA and its synthesizing enzyme glutamate decarboxylase 67 kDa isoform (GAD 67 ) (Sandler and Smith, 1991; Sloviter et al., 1996) . Interestingly, seizures or sustained excitation provoke a transient upregulation of GABA, GAD 67 , and the vesicular GABA transporter (VGAT) mRNA (Schwarzer and Sperk, 1995; Lehmann et al., 1996; Sloviter et al., 1996; Lamas et al., 2001; Ramírez and Gutiérrez, 2001; Gó mez-Lira et al., 2002; Gutiérrez, 2002; Bergersen et al., 2003) . Under these conditions, the activation of GCs provokes, in addition to monosynaptic glutamatergic responses, monosynaptic GABAergic responses on pyramidal cells and interneurons of hippocampal area CA3. Moreover, the emergence of GABAergic transmission depends on protein synthesis (Gutiérrez, 2000 (Gutiérrez, , 2002 Gutiérrez and Heinemann, 2001; RomoParra et al., 2003) .
Thus, adult GCs transiently upregulate their latent GABAergic phenotype in response to demanding conditions, and sustained or repeated depolarization seems to be a common determinant (Gutiérrez, 2002) . But is it necessary for the GCs to be engaged in a hyperexcitable network to express this phenotypic plasticity? Is depolarization the only triggering event? Other candidate factors that can trigger this plasticity are brain-derived neurotrophic factor (BDNF) and GABA, which are released in an activitydependent manner in the DG. GABA itself constitutes a trophic signal in the hippocampus (Ben-Ari et al., 1994), and neurotrophins have a differentiating effect on interneurons in the hip-pocampus (Marty et al., 1996a,b) and cortex (Marty et al., 1997; Patz et al., 2003) , in which they regulate the expression of GABAergic markers. Noteworthy, GCs contain BDNF and also possess the tyrosine receptor kinase B (TrkB) receptor.
Therefore, to gain insight into the determinants of phenotypic plasticity, we studied the effect of synaptic activation of the GCs, in situ, and the effect of activation of glutamate, GABA, and TrkB receptors, in vitro, on the determination of neurotransmitter choice in cultured adult GCs. By using electrophysiological, single-cell reverse transcription (RT)-PCR and immunohistological techniques, we show here that the choice of neurotransmitter in young GCs is programmed, whereas in adult GCs, it can be induced by external determinants, both in situ and in dissociated cultures. This suggests that phenotypic plasticity in GCs is neither limited by a critical developmental period nor restricted by their insertion in their natural network.
Materials and Methods
We used 15-d-old and adult Wistar rats. The latter were allocated into three groups: (1) control nonstimulated, (2) electrically kindled until at least five full blown seizures were provoked, and (3) intraperitoneally injected with the convulsant pentylenetetrazol (PTZ) (60 mg/kg; Sigma, St. Louis, MO) that provokes a single seizure. The kindling procedure was performed as described (Gutiérrez, 2000) .
Hippocampal slice preparation and granule cell culture. Hippocampal slices (400 m thick) were prepared as previously described (Gutiérrez, 2000) and incubated for 1 h in oxygenated artificial CSF (ACSF) containing the following (in mM): 120 NaCl, 5 KCl, 1 CaCl 2 , 2 MgCl 2 , 20 HEPES, 25 glucose, pH 7.35, at room temperature (21°C). They were then incubated for 15 min in ACSF containing 0.9 mg/ml trypsin (type XI; Sigma) and rinsed in ACSF (three times). The DG from two to three slices were dissected, and cells were mechanically dissociated in a total volume of 2 ml of ACSF with polished Pasteur pipettes of different diameters. Aliquots (200 l) of the cell suspension were placed over 1 cm 2 coverslips treated with HistoGrip (Zymed, San Francisco, CA) and kept in culture wells in a CO 2 incubator (NuAire, Plymouth, MN) for 1 h. The preparation medium was then substituted with 250 l of culture medium consisting of the following: Neurobasal A (Invitrogen, Grand Island, NY) supplemented with horse serum (25%; Invitrogen), penicillin/streptomycin (0.5%; Invitrogen), and L-glutamine (0.5 mM; Invitrogen). In some experiments (see Results), tetrodotoxin (TTX) (1 M; Sigma), (DL)-2-amino-5-phosphonovaleric acid (APV) (30 M; Tocris Cookson, Ballwin, MO), and 6-nitro-7-sulfamoylbenzo(f)quinolaxine-2,3-dione (NBQX) (10 M; Tocris Cookson) were present in the preparation and culture media.
Treatment of the granule cells in vitro. Cells dissociated from the DG of young and adult naive rats were cultured for 24 h with or without TTX (see Results). After rinsing the cells three times with control culture medium, they were incubated for 30 min in culture medium containing the following: (1) kainic acid (KA) (5 M; Sigma), (2) KA in the presence of cycloheximide (5 M; Sigma) or APV and NBQX, (3) GABA (50 M), with or without bicuculline (100 M; Sigma), (2S)-3[[(1S)-1-(3,4-dichlorophenyl)-ethyl]amino-2-hydroxypropyl](phenylmethyl)phosphinic acid hydrochloride (CGP55845A) (1 M; a gift from Novartis, New York, NY), and nipecotic acid (1 mM; Sigma), (4) BDNF (100 ng/ml; a gift from Regeneron, Tarrytown, NY) (Li et al., 1998) , with or without the Trk receptor inhibitors methyl-9-( S)-12( R)-epoxy-1 H-diindolo [1,2,3-fg: 3Ј2Ј1Ј-kl] pyrrolo [3,4-i] [1,6]benzodiazocine-2,3,9,10,11,12-hexahydro-10-(R)-hydroxy-9-methyl-1-oxo-10-carboxilate (K252a) (500 nM; Sigma) or 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) (50 M; Sigma). Exposure of the cultures to BDNF was performed in serum-free medium. The cultures were kept in the CO 2 incubator during and 3 h after their exposure to KA, GABA, and BDNF.
Electrophysiological recordings in slices. Combined entorhinal cortexhippocampus slices of control, kindled, and PTZ-treated rats were prepared and placed in an air-to-liquid interface recording chamber at 34 Ϯ 0.5°C. Synaptic responses of CA3b pyramidal cells to DG activation were studied with standard electrophysiological techniques, as described previously (Gutiérrez, 2000) . Additionally, slices of six naive rats were prepared, one-half of which were incubated in oxygenated ACSF containing BDNF (100 ng/ml) and one-half in BDNF plus K252a (500 nM) before the recordings commenced. The experimenter performed the intracellular recordings unaware of the origin of the slices or of the treatment to which they were subjected. The drugs used were diluted in the ACSF, namely, the NMDA receptor antagonist APV (30 M; Tocris Cookson), the non-NMDA receptor antagonist NBQX (10 M; Tocris Cookson), the GABA A receptor antagonist bicuculline methiodide (20 M; Sigma), and the group III metabotropic GluR (mGluR) agonist L(ϩ)-2-amino-4-phosphonobutyric acid (L-AP-4) (1 M; Tocris Cookson).
Electrophysiological recordings in cultures. The cultures were placed in an inverted microscope (Axiovert; Zeiss, Oberkochen, Germany) and recorded in the current-clamp mode of the whole-cell patch-clamp technique with an AxoPatch 200B amplifier (Molecular Devices, Palo Alto, CA) bathed in a sterilized extracellular solution containing the following (in mM): 120 NaCl, 5 KCl, 1 CaCl2, 1.5 MgCl2, 25 glucose, 20 HEPES/ NaOH, at pH 7.4. Signals were filtered at 5 kHz, digitized (Digidata 1200; Molecular Devices), and analyzed with the program pClamp8 (Molecular Devices). We used Sigmacote-treated (Sigma) and sterilized borosilicate pipettes (1.0 mm inner diameter; World Precision Instruments, Sarasota, FL) pulled to yield 3 M⍀ (Flaming-Brown P-97 puller; Sutter Instrument Company, Novato, CA) and filled with sterile intracellular solution (5-8 l) containing the following (in mM): 120 KCl, 1 CaCl2, 2 MgCl2, 11.5 EGTA, 10 HEPES, 20 glucose, at pH 7.4.
Single-cell RT-PCR. The cytosolic content of the recorded cells was extracted, applying gentle negative pressure with the recording pipette, and placed in a PCR tube containing the following: 8 l of buffer (5ϫ) (One-Step RT-PCR kit; Qiagen, Valencia, CA), 1.6 l of dNTPs (final concentration, 10 mM; One-Step RT-PCR kit; Qiagen), 50 pmol of each oligonucleotide, to amplify the selected RNAs (see below), 40 U of RNase inhibitor (Invitrogen, Carlsbad, CA), and 3 l of the mixture of Omniscript reverse transcriptase, Sensiscript reverse transcriptase, and HotStarTaq DNA polymerase (One-Step RT-PCR kit; Qiagen), yielding a final volume of 40 l. The RT-PCR was then performed in a thermocycler (PCR Express; Hybaid Limited, Ashford, UK) as follows: 30 min at 50°C, 15 min at 95°C, 30 s at 94°C, 30 s at 52°C, 1 min at 72°C (40 PCR cycles), and finally, 10 min at 72°C. A second PCR was then conducted with nested oligonucleotides. The product of the first amplifying protocol (3-5 l) was used as template to do a second PCR in a final volume of 25 l. The PCR solution contained the following: PCR buffer (10ϫ) (Amersham Biosciences, Piscataway, NJ), 10 M dNTPs (Invitrogen), 1 U of TaqDNA polymerase (Amersham Biosciences), and 50 pmol of each oligonucleotide. The reaction was performed as follows: 2 min at 94°C, 30 s at 94°C, 30 s at 55-58°C, and 1 min at 72°C (35 PCR cycles). The specific oligonucleotides for each gene were custom-designed (Invitrogen) based on the indicated references. They were as follows: for VGAT (McIntire et al., 1997) , sense and antisense as described (Lamas et al., 2001) ; nested (antisense), 5Ј-TGATCTGGGCCACATTGACC-3Ј; dynorphin (Glasgow et al., 1999) , sense, 5Ј-GAAGTGACAAACAGCGC-TACAC-3Ј; antisense, 5Ј-TGCAACCTCAGAGGGGATCACAAG-3Ј; nested (sense), 5Ј-ACTGCCATAGGGGGATTTGGTAGC-3Ј; VGlut-1 (Ziegler et al., 2002) , sense, 5Ј-ACGTGAACCACTTGGACATC-3Ј; antisense, 5Ј-CAAGAGGCAGTTGAGAAGGA-3Ј; nested, 5Ј-CAGTA-CGTGTTCCTCATAGC-3Ј.
The products were visualized by electrophoresis in agarose gels (1.5%) with ethidium bromide. The expected weight of each final PCR product is as follows: VGAT, 250 bp; VGlut-1, 450 bp; and dynorphin 200 bp. As control experiments, we conducted multiple sham experiments in which the surrounding bath solution was collected and processed in parallel. Also, we did not detect the expression of mRNA in cells from which we omitted the reverse transcriptase from the RT reaction (see Fig. 2 D) .
Immunohistological procedures. The immunohistological procedure started 3 h after the treatment in vitro. For detection of GAD 67 , GAD 65 , calbindin, glutamate, and GABA immunoreactivity, the cultures were fixed for 10 min in 4% paraformaldehyde, rinsed with PBS, and exposed to a droplet of PBS with 0.3% H 2 O 2 . After rinsing twice in PBS, they were incubated in 10% horse serum (Invitrogen), 1% gelatin (Sigma), and 0.1% Tween 20 (Sigma). The cells were then incubated in the presence of the primary antibodies [glutamate at 1:100, GAD 67 at 1:500, GAD 65 at 1:500, calbindin at 1:500 (Chemicon, Temecula, CA), and GABA at 1:100 (Sigma)] in PBS and horse serum (5%) during 18 h. After rinsing, they were incubated in the presence of an appropriate secondary biotinylated IgG (1:500; Jackson ImmunoResearch, West Grove, PA) and processed with the ABC Kit (Vectastain; Vector Laboratories, Burlingame, CA) for 1 h at room temperature. The avidin-biotin complex was developed with diaminobenzidine [10 mg/25 ml PBS (10 mM); Sigma] for 10 min and contrasted with nickel sulfate (30%). In some experiments, we coupled the second antibody to the fluorescein-streptavidin complex (1:200; Vector Laboratories) or Texas Red (1:200; Vector Laboratories) to obtain immunofluorescent preparations. Microscopical observations and photomicrographs were done with an Axiovert microscope (Zeiss) with appropriate digital photographic equipment or with a confocal microscope (MRC 600; Bio-Rad, Hercules, CA). Granule cells and interneurons were identified, counted and photographed in three 1 cm 2 coverslips per experiment. Thus, n in Results represents the number of independent experiments, unless we specify otherwise. Statistical comparisons were assessed with one-way ANOVA and the post hoc Tukey tests. Difference was considered significant if p Ͻ 0.05.
Results

Electrophysiological characterization of synaptic responses provoked by GC activation in hippocampal slices
Before the preparation of the cultures, we characterized the synaptic responses that DG activation produced in CA3 pyramidal cells. The characteristics of these synaptic responses have been thoroughly described previously RomoParra et al., 2003) . In brief, activation of the GCs in slices from 15-d-old rats produced sequences of EPSPs and IPSPs in pyramidal cells of CA3. The perfusion of NBQX and APV blocked the EPSP and isolated a bicuculline-sensitive IPSP with the same onset latency as the control EPSP, whereby the mean latency difference of the EPSP and the IPSP (0.13 Ϯ 0.08 ms) was consistent with a monosynaptic contact (data not shown). These results were obtained in 60 of 60 cells studied. In contrast, in slices from adult naive rats, the perfusion of glutamate receptor antagonists blocked all synaptic responses in 80 of 80 cells recorded (Fig. 1 A) . When slices were obtained from rats having had one or more seizures or from five naive slices stimulated with a kindling-like protocol in vitro (Gutiérrez, 2002) , pyramidal cells recorded in the presence of glutamate receptor blockers responded with a fast IPSP after GC activation (n ϭ 80). Finally, we recorded from slices obtained from six adult naive rats, one-half of which were incubated in BDNF (100 ng/ml) and one-half in BDNF plus K252a for 30 min before the recordings commenced. Before and after these treatments, we stimulated the DG and recorded field potentials in CA3 to assess whether any epileptogenic activity was induced. Neither changes in the waveform of the population responses nor spontaneous or evoked epileptiform activity were found after the BDNF treatment (Fig. 1C) . Granule cell activation in the BDNF-treated slices produced monosynaptic GABAergic responses in 21 of 25 CA3 pyramidal cells, in the presence of glutamate receptor antagonists (Fig. 1 B) . In contrast, in 20 of 20 cells from slices incubated in BDNF plus K252a, glutamate receptors antagonists blocked all synaptic responses (Fig. 1 D) . To corroborate the origin of the responses, we routinely tested the effect of the group III mGluR agonist L-AP-4 (1 M) (Fig. 1 E) , which strongly inhibits the IPSP evoked by GC activation (Gutiérrez, 2000 (Gutiérrez, , 2002 Kasyanov et al., 2004) .
Electrophysiological characterization of GCs in culture conditions
Granule cells were characterized by a spherical or oval-shaped body (mean diameter, 8.3 Ϯ 1.2 m; measured from a random sample of n ϭ 68), usually with a dendritic process. In contrast, DG interneurons had a round soma larger than GCs (12.7 Ϯ 2.6 m; measured from a random sample of n ϭ 30), usually with several processes (Fig. 2) . Granule cells had a resting membrane potential of Ϫ65 Ϯ 1 mV, had an input resistance of 282 Ϯ 25 M⍀ (n ϭ 50; mean Ϯ SEM), and fired a single action potential during a depolarizing DC pulse, whereas interneurons had a resting membrane potential of Ϫ60 Ϯ 2 mV, had an input resistance of 325 Ϯ 31 M⍀ (n ϭ 20; mean Ϯ SEM), and fired action potentials for as long as the cell was depolarized, without accommodation. The action potentials of the GCs were followed by an afterhyperpolarization and a short depolarizing component (Fig.  2 A 1 ) , whereas the action potentials of the interneurons were followed by a hyperpolarizing component (Fig. 2 B 1 ). Taking to- gether the anatomical and electrophysiological characteristics, we could determine a GCs/interneuron ratio of 88/12% in our cultures.
Single-cell RT-PCR
All GCs from adult naive rats (n ϭ 30) expressed mRNAs of VGlut-1 and dynorphin, and 45% also coexpressed a barely detectable band of VGAT mRNA (Figs.  2 A 2 , 3A, E,F ) . In contrast, all GCs from 15-d-old rats (n ϭ 30) expressed mRNAs of VGlut-1, dynorphin, and VGAT (Figs.  2 A 2 , 3E, F ) . For control purposes, we included electrophysiologically identified interneurons of the DG and acutely isolated CA3 pyramidal cells in our analysis (Fig. 2) . Interneurons expressed mRNA of VGAT but not of dynorphin or VGlut1 (n ϭ 10) ( Fig. 2 B 2 ), and pyramidal cells expressed mRNA of VGlut-1 (n ϭ 10) (Fig. 2C 2 ) but not of VGAT or dynorphin. All GC cultures prepared from animals having had one or more seizures in vivo expressed VGlut-1, dynorphin, and VGAT mRNAs (n ϭ 25) (Fig. 3 B, E) .
To assess the effect of a depolarizing stimulus on the expression of the vesicular transporters transcripts in control adult cultures, we exposed them to KA in the presence and absence of antagonists of glutamate receptors and calcium channels. Three hours after the exposure to KA, 15 of 15 GCs coexpressed VGAT and VGlut-1 mRNAs (Fig. 3C 1 ,E) . The KA-induced expression of VGAT mRNA (n ϭ 10) could be prevented by the addition of NBQX and APV to the incubation medium (Fig.  3C 2 ,E) or by using a Ca 2ϩ -free, EGTAcontaining incubation medium (Fig.  3D 1 ,E) . In BDNF-treated cultures, 16 of 24 GCs coexpressed VGAT mRNA and VGlut-1 mRNA (Fig. 3D 2 ,E) . A densitometric analysis of the VGAT mRNA/ VGlut-1 mRNA ratio for each cell showed that the level of expression of VGAT mRNA was significantly higher in BDNFtreated cultures compared with KAtreated cultures (Fig. 3F ) . Also, the ratio of VGAT mRNA/VGlut-1 mRNA expression in 15-d-old rats was significantly higher than that of the control adult GCs expressing VGAT mRNA. In contrast, although all KA-treated adult GCs expressed VGAT mRNA, its expression was not significantly higher than that of the control GCs expressing this transcript (Fig. 3F ) .
Immunohistological determination of the phenotype of adult GCs in culture
With our isolation procedure, we obtained a cell density of 57 Ϯ 8 cells/field (n ϭ 238 1 cm 2 fields). From these, the number of GCs per field was 50 Ϯ 3 and of interneurons was 7 Ϯ 4 in the adult rat preparation. In the 15-d-old rat preparations, the number of GCs per field was 52 Ϯ 10 and of interneurons was 6 Ϯ 2 (n ϭ 18 fields). Because we electrophysiologically characterized a large number of cells, we could later reliably identify whether they were interneurons or GCs. However, additional confirmation of the phenotype was done by determining their immunoreactivity to calbindin and glutamate, and by determining the coexpression of glutamate and GAD 67 or GABA (Fig. 4) . In GCs of 15-d-old rats, 93 Ϯ 2% (n ϭ 3) coexpressed GABA-immunoreactive (IR) and glutamate-IR, 78 Ϯ 1% (n ϭ 3) (Fig. 4 A) were GAD 67 -IR, and 37 Ϯ 2% (n ϭ 3) were GAD 65 -IR (Fig. 5A) . In cultures from adult rats, 95% (n ϭ 3) of the identified GCs were to calbindin, and 100% to glutamate, whereas 41 Ϯ 7% (n ϭ 3) coexpressed glutamate and GAD 67 -IR, 19 Ϯ 5% (n ϭ 3) were GAD 65 -IR and 69 Ϯ 2% (n ϭ 3) were GABA-IR. In contrast, 100% of the identifiable interneurons were GAD 65 -, GAD 67 -, and GABA-IR. We contrasted these results with a set of experiments in which the slicing and dissociation of GCs for the cultures were done in the presence of TTX (1 M). In these conditions, 31 Ϯ 4% (n ϭ 3) of GCs coexpressed glutamate and GAD 67 -IR and 27 Ϯ 3% (n ϭ 3) GABA-IR (Figs. 4 B, 5A, B) . These results indicate that the expression of GABAergic markers can occur in the GCs by the sole isolation procedure and overnight culture. Thus, the subsequent preparation of the cultures was performed in the presence of TTX. We then analyzed GC cultures prepared from in vitro kindled hippocampal slices (n ϭ 4) and from rats having had five kindled seizures in vivo (n ϭ 4). Under these conditions, a strong GAD 67 -IR was found in 99% of the cultured cells, whereas no difference was observed in GAD 65 -IR expression (35%), compared with control preparations.
Activation of glutamate, but not of GABA receptors, induces the expression of the GABAergic markers in adult GC cultures
To explore the effect of the activation of glutamate and GABA receptors on the expression of GABAergic markers in adult GC cultures, they were exposed to either KA or GABA (30 min) and fixed 3 h later to conduct immunohistological studies. After KA exposure, 76 Ϯ 4% of GCs coexpressed GAD 67 -IR and glutamate (n ϭ 3), whereas 75 Ϯ 9% were GABA-IR (Figs. 4 B, C, 5) . The percentage of GAD 65 -IR GCs was 22 Ϯ 8%, which was not different from control conditions (n ϭ 3) (Fig. 5A) . When GCs from 15-d-old rats were exposed to KA, the percentage of cells expressing GAD 67 (81 Ϯ 3%; n ϭ 3), GAD 65 (26 Ϯ 3%; n ϭ 3), or GABA (97 Ϯ 1%; n ϭ 3) was not modified compared with the control condition (Fig. 5A) . The immunoreactivity to GAD 67 and GABA in the KA-treated adult GC cultures was prevented if NBQX plus APV (n ϭ 3), cycloheximide (n ϭ 3), or NiCl 2 (n ϭ 2) was present during KA exposure (Figs. 4C, 5B) .
Exposure of the GCs to GABA alone (n ϭ 3) or in the presence of GABA A and GABA B receptor antagonists (bicuculline and CGP55845A, respectively; n ϭ 2), or of the uptake blocker, nipecotic acid (n ϭ 2), did not produce any change in the number of GABA-and GAD 67 -IR cells, with respect to control conditions (Fig. 5B ).
Brain-derived neurotrophic factor induces the expression of GABAergic markers in adult GC cultures
Exposure of the cultures to BDNF (100 ng/ml) for 30 min in serum-free medium produced a significant increment of GAD 67 -IR, whereas the expression of GABA-IR was not significantly different with respect to control conditions. The percentage of cells that expressed GABA after BDNF incubation was 39 Ϯ 6% (n ϭ 3), but 76 Ϯ 8% were found to coexpress glutamate and GAD 67 . The effect of BDNF was partially dependent on depolarization, because TTX partially prevented its effect. In these conditions, the percentage of GCs with GAD 67 -IR was 44 Ϯ 10% (n ϭ 5), and GABA-IR, 51 Ϯ 10% (n ϭ 5) (Figs. 4 D, 5B) . Interestingly, adding the tyrosine kinase inhibitor with high specificity for the Trk family, K252a, further decreased the number of GABA-IR GCs to 27 Ϯ 6% (n ϭ 5), but its effect on GAD 67 -IR was not different from that observed with TTX alone (50 Ϯ 5%; n ϭ 2). The percentage of GCs that were GAD 67 -IR in the presence of the PKC inhibitor H7 was 24 Ϯ 4% (n ϭ 3) (Figs. 4 D, 5B) . In GC cultures from 15-d-old rats, in which GAD-IR is highly expressed (78%), BDNF further increased the GAD-IR GCs to 96%. These results show that BDNF has a GABA phenotype inductor, but not suppressor, effect.
Discussion
In this work, we show that GC cultures prepared from developing rats normally express a dual glutamatergic/GABAergic phenotype, whereas those prepared from adult rats mainly express a glutamatergic-only phenotype. However, GC cultures prepared from epileptic rats or from slices of naive rats, which were either subjected to strong synaptic stimulation in situ or incubated in the presence of BDNF, coexpressed the markers of the glutamatergic and GABAergic phenotypes. Interestingly, adult, fully differentiated, dissociated GCs in cultures prepared from naive rats can be induced to express a GABAergic phenotype by activation of ionotropic glutamate and neurotrophin receptors. The depolarization-dependent expression of the GABAergic phenotype depends on calcium entry and on protein synthesis. Importantly, the GC cultures that expressed the dual glutamatergic/ GABAergic phenotype were prepared from slices in which we Figure 3 . Granule cells cultured from epileptic rats, and from adult naive rats exposed to KA or BDNF, coexpress VGAT and VGlut-1 mRNA. A, Control adult GCs express VGlut-1 and some express barely detectable levels of VGAT mRNA (cell 3). B, In contrast, all GCs cultured from kindled rats coexpress VGlut and VGAT mRNA. C 1 , KA-treated GC cultures coexpress VGlut-1 and VGAT mRNAs, whereby the expression of the latter is prevented by coincubation of the cells with KA and glutamate receptor blockers (C 2 ) or calcium-free medium (D 1 ). D 2 , Incubation of adult GC cultures with BDNF produces an upregulation of the expression of VGAT mRNA. E, Summary of the results of the single-cell RT-PCR experiments showing the percentage of adult GCs that coexpressed VGlut-1 and VGAT mRNA under the different experimental conditions. *Significant statistical difference obtained by 2 test with respect to adult, control at p Ͻ 0.05 (n ϭ number of cells). F, Densitometric analysis of VGAT mRNA/VGlut-1 mRNA expression ratio under different experimental conditions. Note that the densitometric measurements included different numbers of cells in each condition, as shown in E. *Significant statistical difference obtained by one-way ANOVA at p Ͻ 0.05. Error bars indicate SE.
first electrophysiologically corroborated that GC stimulation provoked monosynaptic glutamatergic, and mGluR-sensitive GABAergic responses in pyramidal cells of area CA3 in the presence of glutamate receptor antagonists.
Although we provided evidence suggesting the presence and activity-dependent upregulation of VGAT mRNA in the GCs (Lamas et al., 2001; Gutiérrez et al., 2003) , our previous experiments were done using DG homogenates. By using single-cell RT-PCR, we now provide direct unequivocal evidence of its presence in developing GCs, of its activity-dependent upregulation in adults in vivo, and of its induction by the activation of glutamate and TrkB receptors in vitro. Moreover, the simultaneous detection of VGAT and VGlut-1 and/or dynorphin mRNAs confirms the identity of the GCs. Our present findings, and those showing that some GABAcontaining neurons do not contain VGAT (Chaudhry et al., 1998) , suggest the existence of a yet-unidentified GABA transporter.
The mechanism that underlies the downregulation of the GABAergic phenotype in the GCs after completion of development is not known. It is possible that, as in embryonic neurons (Borodinsky et al., 2004) , lack of excitation, or the change of GABA action from depolarization to hyperpolarization during development, can downregulate the GABAergic phenotype of the GCs. However, contrary to what happens in the embryonic neuronal population, activation of GABA A and GABA B receptors does not have any overt effect on the neurotransmitter choice in adult GCs. However, we confidently establish that the expression of the GABAergic markers in adult GC cultures depends on prolonged increases of excitability, with the concomitant calcium entry, and on protein synthesis, as we have previously shown in GCs in situ (Gutiérrez, 2002) . The role of calcium on phenotypic differentiation, and especially on the expression of the GABAergic phenotype, has been documented in developing cells (Watt et al., 2000; Ciccolini et al., 2003; Borodinsky et al., 2004) .
This evidence suggests two possibilities: either activity upregulates the expression of GAD and GABA until the concentra- Whereas adding TTX partially prevented the effect of BNDF, the tyrosine kinase inhibitor with high specificity for the Trk family, K252a, and H7, a PKC inhibitor, totally blocked its effect. *Statistically significant difference with respect to the control group at p Ͻ 0.05 (ANOVA). Error bars indicate SE.
tion needed for GABA to be released is reached (Waagepetersen et al., 1999) , or regardless of the intracellular levels of GAD and GABA, an unknown molecular trigger is put in play to enable the release of the available GABA. Whether the blockade of protein synthesis disrupts the synthesis of GAD, GABA, a vesicular transporter protein, or an unknown protein responsible for triggering the release of GABA needs additional investigation.
A second stimulus that we found to be involved in triggering the expression of the GABAergic phenotype in adult GCs is the activation of the TrkB receptor. Exposure of the hippocampal slices to BDNF produced the monosynaptic GABAergic signaling from the mossy fibers to emerge, and at the same time, it was highly effective in upregulating GAD 67 -IR, and VGAT mRNA expression. In agreement with previous reports (Marty et al., 1996a,b) , we show that BDNF is more effective than activity in upregulating mRNA and protein expression in the GCs. Neuronal activity is the main activator of GAD expression with neurotrophins differentially modulating transcription and translation in a context-dependent manner (Patz et al., 2003) . Interestingly, this is the mechanism shown to underlie the maturation of the GABAergic phenotype in hippocampal interneurons (Marty et al., 1996a,b) . Granule cells contain relatively high concentrations of BDNF and NGF, which can be released in vivo by the mossy fibers and dendrites to affect other mossy fibers or other somas, respectively (Blöchl and Thoenen, 1995; Lowenstein and Arsenault, 1996; Conner et al., 1997) . Indeed, the dendritic targeting of BDNF mRNA and its translation to protein can account for the release of this neurotrophin to neighboring GC somata (Tongiorgi et al., 2004) . This suggests that the ligand-receptor interaction occurs by means of an autocrine/paracrine mechanism.
BDNF mRNA expression is increased in adult rat forebrain after limbic seizures (Isackson et al., 1991) , and it has been proposed that enhanced activation of TrkB receptors occurs in the hippocampus during limbic epileptogenesis (Binder et al., 1999) . With our present data, we can propose that BDNF can transcriptionally regulate GABA-related genes in differentiated glutamatergic GCs in an activity-dependent manner. The localization of BDNF mRNA and its translation to protein in dendrites can be an effective means to activate neighboring GCs (Tongiorgi et al., 2004) , and its anterograde transport would effectively provide a mechanism to release BDNF in terminals to produce additional neurotransmitter release by an increase in excitability (Altar and DiStefano, 1998; Elmer et al., 1998; Binder et al., 1999) . Thus, sustained depolarization and release of BDNF (Thoenen, 1995) by excessive excitatory input onto GCs can underlie the expression of their GABAergic phenotype as an adaptive response (Gutiérrez and Heinemann, 2001; Gutiérrez, 2002 Gutiérrez, , 2003 . Indeed, BDNF promotes calcium influx (Berninger et al., 1993) and, as we previously showed, neurotransmitter release (Berzaghi et al., 1995; Thoenen, 1995) . Importantly, it has been shown that BDNF can exert a rapid depolarization in hippocampal neurons by promoting Na ϩ influx through TTX-insensitive channels, and this effect is prevented by K252a (Kafitz et al., 1999; Rose et al., 2003) . In agreement with this, our data show that the GABA phenotype inductor effect of BNDF is completely prevented by K252a and H7, and partially by TTX. The intracellular pathway responsible for this effect, however, cannot be determined with our present data. Therefore, this inductor effect can be either induced by a tyrosine kinase-mediated intracellular cascade put in play by the activation of TrkB receptors leading to gene expression or by the immediate depolarizing effect of BDNF (Berzaghi et al., 1995; Kafitz et al., 1999) , which, as in the case of KA, promotes calcium influx that triggers the expression of the GABAergic markers. It is interesting, however, that our electrophysiological data show that incubation of the slices in BDNF for 30 min does not induce hyperexcitability or epileptiform activity. Therefore, it is likely that the effects of BDNF are secondary to the induction of hyperexcitability.
The effects that we describe on adult GCs indicate that sustained abnormal electrical activity underlies BDNF regulation of neurotransmitter expression. As recently proposed, specific transcription factors might not lead to transmitter switches unless they are involved in programming electrical activity (Borodinsky et al., 2004) . This idea is supported by data showing that BDNF selectively promotes GABAergic maturation (Yamada et al., 2002) , that it switches the excitatory phenotype to an inhibitory phenotype in sympathetic neurons (Yang et al., 2002) , and that it increases the number of GABAergic neurons and synapses differentiated from hippocampal stem cells and in primary cultures (Vicario-Abejó n et al., 1998 , 2000 . From this, it is tempting to speculate that GCs can express a GABAergic phenotype, in addition to the glutamatergic one, probably as a reminiscence of the potentiality expressed by the hippocampal stem cells, which can be differentiated into excitatory and inhibitory neurons (VicarioAbejó n et al., 2000) . In the light of this evidence, our present and previous data prompt the following question: do GCs born during adulthood also express a dual glutamatergic/GABAergic phenotype? This possibility needs to be disclosed, because it is known that developing postnatal GCs express a dual glutamatergic/GABAergic phenotype.
Finally, our data strongly suggest that the activity-dependent release of glutamate and BDNF from GCs underlies this plastic phenotypic expression in neighboring GCs in situ. We conclude that the expression of a dual phenotype in GCs, which are unique in terms of their continuing birth and death throughout life, is neither limited by a critical developmental period nor restricted by their insertion in their natural network. This property makes these cells potentially suitable for ex vivo differentiation and reinstallment in a custom-designed neural circuit equipped with an activity-sensitive phenotypic switch.
